These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9041479)

  • 1. Screening for haemochromatosis.
    Edwards CQ
    J Med Screen; 1996; 3(4):170. PubMed ID: 9041479
    [No Abstract]   [Full Text] [Related]  

  • 2. Population screening for haemochromatosis: a unifying analysis of published intervention trials.
    Bradley LA; Haddow JE; Palomaki GE
    J Med Screen; 1996; 3(4):178-84. PubMed ID: 9041481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population screening for haemochromatosis: expectations based on a study of relatives of symptomatic probands.
    Bradley LA; Haddow JE; Palomaki GE
    J Med Screen; 1996; 3(4):171-7. PubMed ID: 9041480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of cancer by transferrin saturation levels and haemochromatosis genotype: population-based study and meta-analysis.
    Ellervik C; Tybjaerg-Hansen A; Nordestgaard BG
    J Intern Med; 2012 Jan; 271(1):51-63. PubMed ID: 21605201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA determinants in idiopathic haemochromatosis.
    Milman N; Graudal N; Nielsen LS; Sørensen SA
    Dan Med Bull; 1985 Oct; 32(5):262-4. PubMed ID: 4053696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine transferrin saturation measurements in liver clinic patients increases detection of hereditary haemochromatosis.
    Lloyd D; Bhavnani M; Marples J
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):172; author reply 172-3. PubMed ID: 15025815
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for hemochromatosis: phenotype versus genotype.
    Edwards CQ; Griffen LM; Ajioka RS; Kushner JP
    Semin Hematol; 1998 Jan; 35(1):72-6. PubMed ID: 9460810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemochromatosis in a woman with normal transferrin saturation.
    Lopes MJ; Mouro AM; Marques A; Baptista A; Quina M
    Med Chir Dig; 1980; 9(6):519-20. PubMed ID: 7206863
    [No Abstract]   [Full Text] [Related]  

  • 9. Preventing manifestations of hereditary haemochromatosis through population based screening.
    Haddow JE; Ledue TB
    J Med Screen; 1994 Jan; 1(1):16-21. PubMed ID: 8790482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixture models of serum iron measures in population screening for hemochromatosis and iron overload.
    McLaren CE; Li KT; McLaren GD; Gordeuk VR; Snively BM; Reboussin DM; Barton JC; Acton RT; Dawkins FW; Harris EL; Eckfeldt JH; Moses GC; Adams PC
    Transl Res; 2006 Oct; 148(4):196-206. PubMed ID: 17002922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: the modern diagnosis and management of haemochromatosis.
    Adams PC
    Aliment Pharmacol Ther; 2006 Jun; 23(12):1681-91. PubMed ID: 16817911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis.
    Gutteridge JM; Rowley DA; Griffiths E; Halliwell B
    Clin Sci (Lond); 1985 Apr; 68(4):463-7. PubMed ID: 2578915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemochromatosis genotype and iron overload: association with hypertension and left ventricular hypertrophy.
    Ellervik C; Tybjaerg-Hansen A; Appleyard M; Ibsen H; Nordestgaard BG
    J Intern Med; 2010 Sep; 268(3):252-64. PubMed ID: 20337854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of primary hemochromatosis].
    Swinkels DW; Marx JJ
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1404-8. PubMed ID: 10422553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic haemochromatosis.
    Rosalki SB
    Int J Clin Pract; 2002 Oct; 56(8):609-10. PubMed ID: 12425371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of subjects with abnormal iron studies: role of the hepatic iron index.
    Chapman BA; Horton DM; Burt MJ; Romeril KR; Walmsley TA; Grant SJ; George P
    N Z Med J; 1994 Dec; 107(991):504-7. PubMed ID: 7830980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload.
    Townsend A; Drakesmith H
    Lancet; 2002 Mar; 359(9308):786-90. PubMed ID: 11888608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concentration of transferrin iron and transferrin saturation in blood].
    Dudchenko NO; Mykhaĭlyk OM
    Ukr Biokhim Zh (1999); 2000; 72(6):43-50. PubMed ID: 11392783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iron metabolism in hereditary hemochromatosis].
    Andreeva AP; Levina AA; Sattarova DA; Tsibul'skaia MM; Tokarev iuN
    Vrach Delo; 1989 Apr; (4):65-9. PubMed ID: 2756692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.